Epithelial Cell Adhesion Molecule (Ep-CAM) Modulates Cell-cell Interactions Mediated by Classic Cadherins
Overview
Authors
Affiliations
The contribution of noncadherin-type, Ca2+-independent cell-cell adhesion molecules to the organization of epithelial tissues is, as yet, unclear. A homophilic, epithelial Ca2+-independent adhesion molecule (Ep-CAM) is expressed in most epithelia, benign or malignant proliferative lesions, or during embryogenesis. Here we demonstrate that ectopic Ep-CAM, when expressed in cells interconnected by classic cadherins (E- or N-cadherin), induces segregation of the transfectants from the parental cell type in coaggregation assays and in cultured mixed aggregates, respectively. In the latter assay, Ep-CAM-positive transfectants behave like cells with a decreased strength of cell-cell adhesion as compared to the parental cells. Using transfectants with an inducible Ep-CAM-cDNA construct, we demonstrate that increasing expression of Ep-CAM in cadherin-positive cells leads to the gradual abrogation of adherens junctions. Overexpression of Ep-CAM has no influence on the total amount of cellular cadherin, but affects the interaction of cadherins with the cytoskeleton since a substantial decrease in the detergent-insoluble fraction of cadherin molecules was observed. Similarly, the detergent-insoluble fractions of alpha- and beta-catenins decreased in cells overexpressing Ep-CAM. While the total beta-catenin content remains unchanged, a reduction in total cellular alpha-catenin is observed as Ep-CAM expression increases. As the cadherin-mediated cell-cell adhesions diminish, Ep-CAM-mediated intercellular connections become predominant. An adhesion-defective mutant of Ep-CAM lacking the cytoplasmic domain has no effect on the cadherin-mediated cell-cell adhesions. The ability of Ep-CAM to modulate the cadherin-mediated cell-cell interactions, as demonstrated in the present study, suggests a role for this molecule in development of the proliferative, and probably malignant, phenotype of epithelial cells, since an increase of Ep-CAM expression was observed in vivo in association with hyperplastic and malignant proliferation of epithelial cells.
Zelchan R, Chernov V, Medvedeva A, Rybina A, Bragina O, Mishina E Cancers (Basel). 2024; 16(16).
PMID: 39199590 PMC: 11353007. DOI: 10.3390/cancers16162815.
Characterization of EpCAM in thyroid cancer biology by three-dimensional spheroids in vitro model.
Ghiandai V, Grassi E, Gazzano G, Fugazzola L, Persani L Cancer Cell Int. 2024; 24(1):196.
PMID: 38835027 PMC: 11149206. DOI: 10.1186/s12935-024-03378-2.
Regulation of the Function and Expression of EpCAM.
Xiao D, Xiong M, Wang X, Lyu M, Sun H, Cui Y Biomedicines. 2024; 12(5).
PMID: 38791091 PMC: 11117676. DOI: 10.3390/biomedicines12051129.
Menz A, Lony N, Lennartz M, Rico S, Schlichter R, Kind S Diagnostics (Basel). 2024; 14(10).
PMID: 38786342 PMC: 11120328. DOI: 10.3390/diagnostics14101044.
MacLean M, Walker O, Arun R, Fernando W, Marcato P Int J Mol Sci. 2024; 25(7).
PMID: 38612911 PMC: 11012648. DOI: 10.3390/ijms25074102.